- Ketryx is an AI-powered compliance platform based in Cambridge, Massachusetts, focused on helping life sciences companies accelerate product innovation while ensuring safety and regulatory compliance.
- In September 2025, Ketryx raised $39 million in a Series B funding round led by Transformation Capital, bringing its total funding to over $55 million to enhance its AI compliance tools.
- The company serves top life science firms and Fortune 500 companies, automating validation and regulatory workflows, which has reportedly reduced documentation time by up to 90% and accelerated release cycles by more than 10 times.
- Ketryx's ideal buyers are life sciences companies facing challenges in balancing rapid innovation with stringent compliance requirements, making their solutions critical as the demand for validated AI in regulated environments surges.
Ketryx's workforce is organized into 11 departments, with Operations and Sales being the largest, comprising 14 and 13 employees, respectively. Information Technology follows with 7 employees, indicating a strong emphasis on technical support and infrastructure. The presence of smaller departments such as Human Resources and Finance, with 3 and 2 employees respectively, suggests a lean operational model that prioritizes core functions while maintaining essential support services.
Ketryx operates across 17 locations, with a notable concentration in Boston, MA, housing 6 employees, and Cambridge, MA, with 3 employees. Other significant locations include Austin, TX, and Framingham, MA, each contributing 2 employees. The 'Other' category, accounting for 26 employees, indicates a distributed workforce that may support remote operations and flexibility, enhancing the company’s ability to tap into diverse talent pools across the country.
